Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1965 2
1966 2
1967 3
1968 1
1971 1
1974 4
1975 1
1976 1
1977 1
1981 2
1982 1
1983 3
1984 1
1986 2
1988 2
1989 6
1990 5
1991 6
1992 2
1993 4
1994 2
1995 1
1996 6
1997 3
1998 6
1999 9
2000 9
2001 5
2002 2
2003 2
2004 1
2005 8
2006 7
2007 5
2008 6
2009 9
2010 6
2012 3
2013 5
2014 4
2015 1
2016 6
2017 4
2018 8
2019 5
2020 10
2021 9
2022 7
Text availability
Article attribute
Article type
Publication date

Search Results

186 results
Results by year
Filters applied: . Clear all
Page 1
Randomized, Phase II Study of Trastuzumab Beyond Progression in Patients With HER2-Positive Advanced Gastric or Gastroesophageal Junction Cancer: WJOG7112G (T-ACT Study).
Makiyama A, Sukawa Y, Kashiwada T, Kawada J, Hosokawa A, Horie Y, Tsuji A, Moriwaki T, Tanioka H, Shinozaki K, Uchino K, Yasui H, Tsukuda H, Nishikawa K, Ishida H, Yamanaka T, Yamazaki K, Hironaka S, Esaki T, Boku N, Hyodo I, Muro K. Makiyama A, et al. Among authors: tanioka h. J Clin Oncol. 2020 Jun 10;38(17):1919-1927. doi: 10.1200/JCO.19.03077. Epub 2020 Mar 24. J Clin Oncol. 2020. PMID: 32208960 Clinical Trial.
[Introduction].
Yamaguchi Y, Katata Y, Okawaki M, Yamamura M, Tanioka H, Nagasaka T. Yamaguchi Y, et al. Among authors: tanioka h. Gan To Kagaku Ryoho. 2018 Jul;45(7):1017-1020. Gan To Kagaku Ryoho. 2018. PMID: 30042263 Japanese.
Hepatectomy Followed by Adjuvant Chemotherapy with 3-Month Capecitabine Plus Oxaliplatin for Colorectal Cancer Liver Metastases.
Satake H, Hashida H, Tanioka H, Miyake Y, Yoshioka S, Watanabe T, Matsuura M, Kyogoku T, Inukai M, Kotake T, Okita Y, Matsumoto T, Yasui H, Kotaka M, Kato T, Kaihara S, Tsuji A. Satake H, et al. Among authors: tanioka h. Oncologist. 2021 Jul;26(7):e1125-e1132. doi: 10.1002/onco.13816. Epub 2021 May 31. Oncologist. 2021. PMID: 33977607 Free PMC article.
A phase II study of FOLFOXIRI plus bevacizumab as initial chemotherapy for patients with untreated metastatic colorectal cancer: TRICC1414 (BeTRI).
Shinozaki K, Yamada T, Nasu J, Matsumoto T, Yuasa Y, Shiraishi T, Nagano H, Moriyama I, Fujiwara T, Miguchi M, Yoshida R, Nozaka K, Tanioka H, Nagasaka T, Kurisu Y, Kobayashi M, Tsuchihashi K, Inukai M, Kikuchi T, Nishina T. Shinozaki K, et al. Among authors: tanioka h. Int J Clin Oncol. 2021 Feb;26(2):399-408. doi: 10.1007/s10147-020-01811-w. Epub 2020 Oct 23. Int J Clin Oncol. 2021. PMID: 33097971 Free PMC article. Clinical Trial.
186 results